Bio-Rad Laboratories, Inc. (BIO)
369.14
+13.57
(+3.82%)
USD |
NYSE |
Oct 02, 16:00
368.97
-0.17
(-0.05%)
Pre-Market: 20:00
Bio-Rad Laboratories Market Cap : 9.870B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 9.870B |
| October 01, 2026 | 9.507B |
| September 30, 2026 | 10.10B |
| September 29, 2026 | 10.15B |
| September 28, 2026 | 10.10B |
| September 25, 2026 | 10.19B |
| September 24, 2026 | 10.36B |
| September 23, 2026 | 10.13B |
| September 22, 2026 | 10.15B |
| September 21, 2026 | 10.09B |
| September 18, 2026 | 10.06B |
| September 17, 2026 | 10.22B |
| September 16, 2026 | 10.13B |
| September 15, 2026 | 10.11B |
| September 14, 2026 | 9.854B |
| September 11, 2026 | 9.875B |
| September 10, 2026 | 9.860B |
| September 09, 2026 | 10.08B |
| September 08, 2026 | 10.16B |
| September 04, 2026 | 10.32B |
| September 03, 2026 | 10.37B |
| September 02, 2026 | 10.39B |
| September 01, 2026 | 10.19B |
| August 31, 2026 | 10.32B |
| August 28, 2026 | 10.37B |
| Date | Value |
|---|---|
| August 27, 2026 | 10.43B |
| August 26, 2026 | 10.39B |
| August 25, 2026 | 10.44B |
| August 24, 2026 | 10.21B |
| August 21, 2026 | 10.16B |
| August 20, 2026 | 10.07B |
| August 19, 2026 | 9.740B |
| August 18, 2026 | 9.430B |
| August 17, 2026 | 9.498B |
| August 14, 2026 | 9.526B |
| August 13, 2026 | 9.657B |
| August 12, 2026 | 9.681B |
| August 11, 2026 | 9.525B |
| August 10, 2026 | 9.480B |
| August 07, 2026 | 9.424B |
| August 06, 2026 | 9.156B |
| August 05, 2026 | 9.301B |
| August 04, 2026 | 8.901B |
| August 03, 2026 | 8.949B |
| July 31, 2026 | 8.732B |
| July 30, 2026 | 8.765B |
| July 29, 2026 | 8.780B |
| July 28, 2026 | 8.880B |
| July 27, 2026 | 8.489B |
| July 24, 2026 | 8.436B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 242.11B |
| Agilent Technologies, Inc. | 47.31B |
| Danaher Corp. | 150.46B |
| Illumina, Inc. | 41.23B |
| Revvity, Inc. | 16.91B |
Market Cap Related Metrics
| PE Ratio | 44.72 |
| PS Ratio | 3.839 |
| Price to Book Value | 1.376 |
| Price to Free Cash Flow | 28.15 |
| Price | 369.14 |
| Earnings Yield | 2.24% |
| Operating PE Ratio | 42.30 |
| Normalized PE Ratio | 57.54 |